Irbesartan Market
1 Study Coverage
1.1 Irbesartan Product Introduction
1.2 Market by Type
1.2.1 Global Irbesartan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Combination Drugs
1.2.3 Prescribed Drugs
1.3 Market by Application
1.3.1 Global Irbesartan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hyperlipidemia
1.3.3 High Blood Pressure
1.3.4 Heart Failure
1.3.5 Kidney Disease
1.3.6 Fibrous Fibrillation
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Irbesartan Sales Estimates and Forecasts 2017-2028
2.2 Global Irbesartan Revenue Estimates and Forecasts 2017-2028
2.3 Global Irbesartan Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Irbesartan Sales by Region
2.4.1 Global Irbesartan Sales by Region (2017-2022)
2.4.2 Global Sales Irbesartan by Region (2023-2028)
2.5 Global Irbesartan Revenue by Region
2.5.1 Global Irbesartan Revenue by Region (2017-2022)
2.5.2 Global Irbesartan Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Irbesartan Sales by Manufacturers
3.1.1 Global Top Irbesartan Manufacturers by Sales (2017-2022)
3.1.2 Global Irbesartan Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Irbesartan in 2021
3.2 Global Irbesartan Revenue by Manufacturers
3.2.1 Global Irbesartan Revenue by Manufacturers (2017-2022)
3.2.2 Global Irbesartan Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Irbesartan Revenue in 2021
3.3 Global Irbesartan Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Irbesartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Irbesartan Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Irbesartan Sales by Type
4.1.1 Global Irbesartan Historical Sales by Type (2017-2022)
4.1.2 Global Irbesartan Forecasted Sales by Type (2023-2028)
4.1.3 Global Irbesartan Sales Market Share by Type (2017-2028)
4.2 Global Irbesartan Revenue by Type
4.2.1 Global Irbesartan Historical Revenue by Type (2017-2022)
4.2.2 Global Irbesartan Forecasted Revenue by Type (2023-2028)
4.2.3 Global Irbesartan Revenue Market Share by Type (2017-2028)
4.3 Global Irbesartan Price by Type
4.3.1 Global Irbesartan Price by Type (2017-2022)
4.3.2 Global Irbesartan Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Irbesartan Sales by Application
5.1.1 Global Irbesartan Historical Sales by Application (2017-2022)
5.1.2 Global Irbesartan Forecasted Sales by Application (2023-2028)
5.1.3 Global Irbesartan Sales Market Share by Application (2017-2028)
5.2 Global Irbesartan Revenue by Application
5.2.1 Global Irbesartan Historical Revenue by Application (2017-2022)
5.2.2 Global Irbesartan Forecasted Revenue by Application (2023-2028)
5.2.3 Global Irbesartan Revenue Market Share by Application (2017-2028)
5.3 Global Irbesartan Price by Application
5.3.1 Global Irbesartan Price by Application (2017-2022)
5.3.2 Global Irbesartan Price Forecast by Application (2023-2028)
6 North America
6.1 North America Irbesartan Market Size by Type
6.1.1 North America Irbesartan Sales by Type (2017-2028)
6.1.2 North America Irbesartan Revenue by Type (2017-2028)
6.2 North America Irbesartan Market Size by Application
6.2.1 North America Irbesartan Sales by Application (2017-2028)
6.2.2 North America Irbesartan Revenue by Application (2017-2028)
6.3 North America Irbesartan Market Size by Country
6.3.1 North America Irbesartan Sales by Country (2017-2028)
6.3.2 North America Irbesartan Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Irbesartan Market Size by Type
7.1.1 Europe Irbesartan Sales by Type (2017-2028)
7.1.2 Europe Irbesartan Revenue by Type (2017-2028)
7.2 Europe Irbesartan Market Size by Application
7.2.1 Europe Irbesartan Sales by Application (2017-2028)
7.2.2 Europe Irbesartan Revenue by Application (2017-2028)
7.3 Europe Irbesartan Market Size by Country
7.3.1 Europe Irbesartan Sales by Country (2017-2028)
7.3.2 Europe Irbesartan Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Irbesartan Market Size by Type
8.1.1 Asia Pacific Irbesartan Sales by Type (2017-2028)
8.1.2 Asia Pacific Irbesartan Revenue by Type (2017-2028)
8.2 Asia Pacific Irbesartan Market Size by Application
8.2.1 Asia Pacific Irbesartan Sales by Application (2017-2028)
8.2.2 Asia Pacific Irbesartan Revenue by Application (2017-2028)
8.3 Asia Pacific Irbesartan Market Size by Region
8.3.1 Asia Pacific Irbesartan Sales by Region (2017-2028)
8.3.2 Asia Pacific Irbesartan Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Irbesartan Market Size by Type
9.1.1 Latin America Irbesartan Sales by Type (2017-2028)
9.1.2 Latin America Irbesartan Revenue by Type (2017-2028)
9.2 Latin America Irbesartan Market Size by Application
9.2.1 Latin America Irbesartan Sales by Application (2017-2028)
9.2.2 Latin America Irbesartan Revenue by Application (2017-2028)
9.3 Latin America Irbesartan Market Size by Country
9.3.1 Latin America Irbesartan Sales by Country (2017-2028)
9.3.2 Latin America Irbesartan Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Irbesartan Market Size by Type
10.1.1 Middle East and Africa Irbesartan Sales by Type (2017-2028)
10.1.2 Middle East and Africa Irbesartan Revenue by Type (2017-2028)
10.2 Middle East and Africa Irbesartan Market Size by Application
10.2.1 Middle East and Africa Irbesartan Sales by Application (2017-2028)
10.2.2 Middle East and Africa Irbesartan Revenue by Application (2017-2028)
10.3 Middle East and Africa Irbesartan Market Size by Country
10.3.1 Middle East and Africa Irbesartan Sales by Country (2017-2028)
10.3.2 Middle East and Africa Irbesartan Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 BMS
11.3.1 BMS Corporation Information
11.3.2 BMS Overview
11.3.3 BMS Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BMS Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BMS Recent Developments
11.4 Sumitomo Dainippon Pharma
11.4.1 Sumitomo Dainippon Pharma Corporation Information
11.4.2 Sumitomo Dainippon Pharma Overview
11.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sumitomo Dainippon Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sumitomo Dainippon Pharma Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Shionogi
11.6.1 Shionogi Corporation Information
11.6.2 Shionogi Overview
11.6.3 Shionogi Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Shionogi Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shionogi Recent Developments
11.7 Hanall
11.7.1 Hanall Corporation Information
11.7.2 Hanall Overview
11.7.3 Hanall Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hanall Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hanall Recent Developments
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Corporation Information
11.8.2 Taj Pharmaceuticals Overview
11.8.3 Taj Pharmaceuticals Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Taj Pharmaceuticals Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Taj Pharmaceuticals Recent Developments
11.9 Apotex
11.9.1 Apotex Corporation Information
11.9.2 Apotex Overview
11.9.3 Apotex Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Apotex Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Apotex Recent Developments
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Corporation Information
11.10.2 Jiangsu Hengrui Medicine Overview
11.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Jiangsu Hengrui Medicine Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jiangsu Hengrui Medicine Recent Developments
11.11 Verdant Life Sciences
11.11.1 Verdant Life Sciences Corporation Information
11.11.2 Verdant Life Sciences Overview
11.11.3 Verdant Life Sciences Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Verdant Life Sciences Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Verdant Life Sciences Recent Developments
11.12 Angita Pharma
11.12.1 Angita Pharma Corporation Information
11.12.2 Angita Pharma Overview
11.12.3 Angita Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Angita Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Angita Pharma Recent Developments
11.13 Auro Pharma
11.13.1 Auro Pharma Corporation Information
11.13.2 Auro Pharma Overview
11.13.3 Auro Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Auro Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Auro Pharma Recent Developments
11.14 Avanstra
11.14.1 Avanstra Corporation Information
11.14.2 Avanstra Overview
11.14.3 Avanstra Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Avanstra Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Avanstra Recent Developments
11.15 Zhuhai Rundu Pharma
11.15.1 Zhuhai Rundu Pharma Corporation Information
11.15.2 Zhuhai Rundu Pharma Overview
11.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Zhuhai Rundu Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Zhuhai Rundu Pharma Recent Developments
11.16 Xiansheng Pharmaceutical
11.16.1 Xiansheng Pharmaceutical Corporation Information
11.16.2 Xiansheng Pharmaceutical Overview
11.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Xiansheng Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Xiansheng Pharmaceutical Recent Developments
11.17 CTTQ
11.17.1 CTTQ Corporation Information
11.17.2 CTTQ Overview
11.17.3 CTTQ Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 CTTQ Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 CTTQ Recent Developments
11.18 Tianjin Huairen Pharmaceutical
11.18.1 Tianjin Huairen Pharmaceutical Corporation Information
11.18.2 Tianjin Huairen Pharmaceutical Overview
11.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Tianjin Huairen Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Tianjin Huairen Pharmaceutical Recent Developments
11.19 Jiangsu Wangao Pharmaceutical
11.19.1 Jiangsu Wangao Pharmaceutical Corporation Information
11.19.2 Jiangsu Wangao Pharmaceutical Overview
11.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Jiangsu Wangao Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Jiangsu Wangao Pharmaceutical Recent Developments
11.20 Zhejiang Huahai Pharmaceutical
11.20.1 Zhejiang Huahai Pharmaceutical Corporation Information
11.20.2 Zhejiang Huahai Pharmaceutical Overview
11.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Zhejiang Huahai Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Zhejiang Huahai Pharmaceutical Recent Developments
11.21 Zhejiang Ainuo Pharmaceutical
11.21.1 Zhejiang Ainuo Pharmaceutical Corporation Information
11.21.2 Zhejiang Ainuo Pharmaceutical Overview
11.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Zhejiang Ainuo Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Zhejiang Ainuo Pharmaceutical Recent Developments
11.22 Yuanhe Pharmaceutical
11.22.1 Yuanhe Pharmaceutical Corporation Information
11.22.2 Yuanhe Pharmaceutical Overview
11.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Yuanhe Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Yuanhe Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Irbesartan Industry Chain Analysis
12.2 Irbesartan Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Irbesartan Production Mode & Process
12.4 Irbesartan Sales and Marketing
12.4.1 Irbesartan Sales Channels
12.4.2 Irbesartan Distributors
12.5 Irbesartan Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Irbesartan Industry Trends
13.2 Irbesartan Market Drivers
13.3 Irbesartan Market Challenges
13.4 Irbesartan Market Restraints
14 Key Findings in The Global Irbesartan Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Irbesartan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Combination Drugs
Table 3. Major Manufacturers of Prescribed Drugs
Table 4. Global Irbesartan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Irbesartan Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Irbesartan Sales by Region (2017-2022) & (KG)
Table 7. Global Irbesartan Sales Market Share by Region (2017-2022)
Table 8. Global Irbesartan Sales by Region (2023-2028) & (KG)
Table 9. Global Irbesartan Sales Market Share by Region (2023-2028)
Table 10. Global Irbesartan Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Irbesartan Revenue Market Share by Region (2017-2022)
Table 12. Global Irbesartan Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Irbesartan Revenue Market Share by Region (2023-2028)
Table 14. Global Irbesartan Sales by Manufacturers (2017-2022) & (KG)
Table 15. Global Irbesartan Sales Share by Manufacturers (2017-2022)
Table 16. Global Irbesartan Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Irbesartan Revenue Share by Manufacturers (2017-2022)
Table 18. Irbesartan Price by Manufacturers (2017-2022) &(US$/G)
Table 19. Global Irbesartan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Irbesartan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irbesartan as of 2021)
Table 21. Irbesartan Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Irbesartan Product Offered
Table 23. Date of Manufacturers Enter into Irbesartan Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Irbesartan Sales by Type (2017-2022) & (KG)
Table 26. Global Irbesartan Sales by Type (2023-2028) & (KG)
Table 27. Global Irbesartan Sales Share by Type (2017-2022)
Table 28. Global Irbesartan Sales Share by Type (2023-2028)
Table 29. Global Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Irbesartan Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Irbesartan Revenue Share by Type (2017-2022)
Table 32. Global Irbesartan Revenue Share by Type (2023-2028)
Table 33. Irbesartan Price by Type (2017-2022) & (US$/G)
Table 34. Global Irbesartan Price Forecast by Type (2023-2028) & (US$/G)
Table 35. Global Irbesartan Sales by Application (2017-2022) & (KG)
Table 36. Global Irbesartan Sales by Application (2023-2028) & (KG)
Table 37. Global Irbesartan Sales Share by Application (2017-2022)
Table 38. Global Irbesartan Sales Share by Application (2023-2028)
Table 39. Global Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Irbesartan Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Irbesartan Revenue Share by Application (2017-2022)
Table 42. Global Irbesartan Revenue Share by Application (2023-2028)
Table 43. Irbesartan Price by Application (2017-2022) & (US$/G)
Table 44. Global Irbesartan Price Forecast by Application (2023-2028) & (US$/G)
Table 45. North America Irbesartan Sales by Type (2017-2022) & (KG)
Table 46. North America Irbesartan Sales by Type (2023-2028) & (KG)
Table 47. North America Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Irbesartan Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Irbesartan Sales by Application (2017-2022) & (KG)
Table 50. North America Irbesartan Sales by Application (2023-2028) & (KG)
Table 51. North America Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Irbesartan Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Irbesartan Sales by Country (2017-2022) & (KG)
Table 54. North America Irbesartan Sales by Country (2023-2028) & (KG)
Table 55. North America Irbesartan Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Irbesartan Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Irbesartan Sales by Type (2017-2022) & (KG)
Table 58. Europe Irbesartan Sales by Type (2023-2028) & (KG)
Table 59. Europe Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Irbesartan Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Irbesartan Sales by Application (2017-2022) & (KG)
Table 62. Europe Irbesartan Sales by Application (2023-2028) & (KG)
Table 63. Europe Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Irbesartan Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Irbesartan Sales by Country (2017-2022) & (KG)
Table 66. Europe Irbesartan Sales by Country (2023-2028) & (KG)
Table 67. Europe Irbesartan Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Irbesartan Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Irbesartan Sales by Type (2017-2022) & (KG)
Table 70. Asia Pacific Irbesartan Sales by Type (2023-2028) & (KG)
Table 71. Asia Pacific Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Irbesartan Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Irbesartan Sales by Application (2017-2022) & (KG)
Table 74. Asia Pacific Irbesartan Sales by Application (2023-2028) & (KG)
Table 75. Asia Pacific Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Irbesartan Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Irbesartan Sales by Region (2017-2022) & (KG)
Table 78. Asia Pacific Irbesartan Sales by Region (2023-2028) & (KG)
Table 79. Asia Pacific Irbesartan Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Irbesartan Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Irbesartan Sales by Type (2017-2022) & (KG)
Table 82. Latin America Irbesartan Sales by Type (2023-2028) & (KG)
Table 83. Latin America Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Irbesartan Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Irbesartan Sales by Application (2017-2022) & (KG)
Table 86. Latin America Irbesartan Sales by Application (2023-2028) & (KG)
Table 87. Latin America Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Irbesartan Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Irbesartan Sales by Country (2017-2022) & (KG)
Table 90. Latin America Irbesartan Sales by Country (2023-2028) & (KG)
Table 91. Latin America Irbesartan Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Irbesartan Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Irbesartan Sales by Type (2017-2022) & (KG)
Table 94. Middle East and Africa Irbesartan Sales by Type (2023-2028) & (KG)
Table 95. Middle East and Africa Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Irbesartan Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Irbesartan Sales by Application (2017-2022) & (KG)
Table 98. Middle East and Africa Irbesartan Sales by Application (2023-2028) & (KG)
Table 99. Middle East and Africa Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Irbesartan Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Irbesartan Sales by Country (2017-2022) & (KG)
Table 102. Middle East and Africa Irbesartan Sales by Country (2023-2028) & (KG)
Table 103. Middle East and Africa Irbesartan Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Irbesartan Revenue by Country (2023-2028) & (US$ Million)
Table 105. Teva Corporation Information
Table 106. Teva Description and Major Businesses
Table 107. Teva Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 108. Teva Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Teva Recent Developments
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Major Businesses
Table 112. Sanofi Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 113. Sanofi Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Sanofi Recent Developments
Table 115. BMS Corporation Information
Table 116. BMS Description and Major Businesses
Table 117. BMS Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 118. BMS Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. BMS Recent Developments
Table 120. Sumitomo Dainippon Pharma Corporation Information
Table 121. Sumitomo Dainippon Pharma Description and Major Businesses
Table 122. Sumitomo Dainippon Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 123. Sumitomo Dainippon Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sumitomo Dainippon Pharma Recent Developments
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Major Businesses
Table 127. Novartis Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 128. Novartis Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Novartis Recent Developments
Table 130. Shionogi Corporation Information
Table 131. Shionogi Description and Major Businesses
Table 132. Shionogi Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 133. Shionogi Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Shionogi Recent Developments
Table 135. Hanall Corporation Information
Table 136. Hanall Description and Major Businesses
Table 137. Hanall Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 138. Hanall Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Hanall Recent Developments
Table 140. Taj Pharmaceuticals Corporation Information
Table 141. Taj Pharmaceuticals Description and Major Businesses
Table 142. Taj Pharmaceuticals Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 143. Taj Pharmaceuticals Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Taj Pharmaceuticals Recent Developments
Table 145. Apotex Corporation Information
Table 146. Apotex Description and Major Businesses
Table 147. Apotex Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 148. Apotex Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Apotex Recent Developments
Table 150. Jiangsu Hengrui Medicine Corporation Information
Table 151. Jiangsu Hengrui Medicine Description and Major Businesses
Table 152. Jiangsu Hengrui Medicine Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 153. Jiangsu Hengrui Medicine Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Jiangsu Hengrui Medicine Recent Developments
Table 155. Verdant Life Sciences Corporation Information
Table 156. Verdant Life Sciences Description and Major Businesses
Table 157. Verdant Life Sciences Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 158. Verdant Life Sciences Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Verdant Life Sciences Recent Developments
Table 160. Angita Pharma Corporation Information
Table 161. Angita Pharma Description and Major Businesses
Table 162. Angita Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 163. Angita Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Angita Pharma Recent Developments
Table 165. Auro Pharma Corporation Information
Table 166. Auro Pharma Description and Major Businesses
Table 167. Auro Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 168. Auro Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Auro Pharma Recent Developments
Table 170. Avanstra Corporation Information
Table 171. Avanstra Description and Major Businesses
Table 172. Avanstra Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 173. Avanstra Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Avanstra Recent Developments
Table 175. Zhuhai Rundu Pharma Corporation Information
Table 176. Zhuhai Rundu Pharma Description and Major Businesses
Table 177. Zhuhai Rundu Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 178. Zhuhai Rundu Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Zhuhai Rundu Pharma Recent Developments
Table 180. Xiansheng Pharmaceutical Corporation Information
Table 181. Xiansheng Pharmaceutical Description and Major Businesses
Table 182. Xiansheng Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 183. Xiansheng Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Xiansheng Pharmaceutical Recent Developments
Table 185. CTTQ Corporation Information
Table 186. CTTQ Description and Major Businesses
Table 187. CTTQ Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 188. CTTQ Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. CTTQ Recent Developments
Table 190. Tianjin Huairen Pharmaceutical Corporation Information
Table 191. Tianjin Huairen Pharmaceutical Description and Major Businesses
Table 192. Tianjin Huairen Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 193. Tianjin Huairen Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Tianjin Huairen Pharmaceutical Recent Developments
Table 195. Jiangsu Wangao Pharmaceutical Corporation Information
Table 196. Jiangsu Wangao Pharmaceutical Description and Major Businesses
Table 197. Jiangsu Wangao Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 198. Jiangsu Wangao Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Jiangsu Wangao Pharmaceutical Recent Developments
Table 200. Zhejiang Huahai Pharmaceutical Corporation Information
Table 201. Zhejiang Huahai Pharmaceutical Description and Major Businesses
Table 202. Zhejiang Huahai Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 203. Zhejiang Huahai Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 204. Zhejiang Huahai Pharmaceutical Recent Developments
Table 205. Zhejiang Ainuo Pharmaceutical Corporation Information
Table 206. Zhejiang Ainuo Pharmaceutical Description and Major Businesses
Table 207. Zhejiang Ainuo Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 208. Zhejiang Ainuo Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 209. Zhejiang Ainuo Pharmaceutical Recent Developments
Table 210. Yuanhe Pharmaceutical Corporation Information
Table 211. Yuanhe Pharmaceutical Description and Major Businesses
Table 212. Yuanhe Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 213. Yuanhe Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 214. Yuanhe Pharmaceutical Recent Developments
Table 215. Key Raw Materials Lists
Table 216. Raw Materials Key Suppliers Lists
Table 217. Irbesartan Distributors List
Table 218. Irbesartan Customers List
Table 219. Irbesartan Market Trends
Table 220. Irbesartan Market Drivers
Table 221. Irbesartan Market Challenges
Table 222. Irbesartan Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Irbesartan Product Picture
Figure 3. Global Irbesartan Market Share by Type in 2021 & 2028
Figure 3. Combination Drugs Product Picture
Figure 4. Prescribed Drugs Product Picture
Figure 5. Global Irbesartan Market Share by Application in 2021 & 2028
Figure 6. Hyperlipidemia
Figure 7. High Blood Pressure
Figure 8. Heart Failure
Figure 9. Kidney Disease
Figure 10. Fibrous Fibrillation
Figure 11. Other
Figure 12. Irbesartan Report Years Considered
Figure 13. Global Irbesartan Sales 2017-2028 (KG)
Figure 14. Global Irbesartan Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Irbesartan Revenue 2017-2028 (US$ Million)
Figure 16. Global Irbesartan Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Irbesartan Sales Market Share by Region (2017-2022)
Figure 18. Global Irbesartan Sales Market Share by Region (2023-2028)
Figure 19. North America Irbesartan Sales YoY (2017-2028) & (KG)
Figure 20. North America Irbesartan Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Irbesartan Sales YoY (2017-2028) & (KG)
Figure 22. Europe Irbesartan Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Irbesartan Sales YoY (2017-2028) & (KG)
Figure 24. Asia-Pacific Irbesartan Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Irbesartan Sales YoY (2017-2028) & (KG)
Figure 26. Latin America Irbesartan Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Irbesartan Sales YoY (2017-2028) & (KG)
Figure 28. Middle East & Africa Irbesartan Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Irbesartan Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Irbesartan in the World: Market Share by Irbesartan Revenue in 2021
Figure 31. Global Irbesartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Irbesartan Sales Market Share by Type (2017-2028)
Figure 33. Global Irbesartan Revenue Market Share by Type (2017-2028)
Figure 34. Global Irbesartan Sales Market Share by Application (2017-2028)
Figure 35. Global Irbesartan Revenue Market Share by Application (2017-2028)
Figure 36. North America Irbesartan Sales Market Share by Type (2017-2028)
Figure 37. North America Irbesartan Revenue Market Share by Type (2017-2028)
Figure 38. North America Irbesartan Sales Market Share by Application (2017-2028)
Figure 39. North America Irbesartan Revenue Market Share by Application (2017-2028)
Figure 40. North America Irbesartan Sales Share by Country (2017-2028)
Figure 41. North America Irbesartan Revenue Share by Country (2017-2028)
Figure 42. U.S. Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Irbesartan Sales Market Share by Type (2017-2028)
Figure 45. Europe Irbesartan Revenue Market Share by Type (2017-2028)
Figure 46. Europe Irbesartan Sales Market Share by Application (2017-2028)
Figure 47. Europe Irbesartan Revenue Market Share by Application (2017-2028)
Figure 48. Europe Irbesartan Sales Share by Country (2017-2028)
Figure 49. Europe Irbesartan Revenue Share by Country (2017-2028)
Figure 50. Germany Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 51. France Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Irbesartan Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Irbesartan Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Irbesartan Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Irbesartan Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Irbesartan Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Irbesartan Revenue Share by Region (2017-2028)
Figure 61. China Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 64. India Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Irbesartan Sales Market Share by Type (2017-2028)
Figure 72. Latin America Irbesartan Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Irbesartan Sales Market Share by Application (2017-2028)
Figure 74. Latin America Irbesartan Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Irbesartan Sales Share by Country (2017-2028)
Figure 76. Latin America Irbesartan Revenue Share by Country (2017-2028)
Figure 77. Mexico Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Irbesartan Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Irbesartan Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Irbesartan Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Irbesartan Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Irbesartan Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Irbesartan Revenue Share by Country (2017-2028)
Figure 86. Turkey Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Irbesartan Revenue (2017-2028) & (US$ Million)
Figure 89. Irbesartan Value Chain
Figure 90. Irbesartan Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
Industry Market Size
